Cancer Research UK launches 'spaceship' smartphone game to seek cancer cures
2/05/2014
Cancer Research UK has unveiled Play to Cure: Genes in Space - a world-first mobile phone game in which people across the globe will be able to help scientists unravel gene data to find the answers to some of cancer's toughest questions.It is available to download now for free here for anyone with an Android or Apple Smartphone.
Queen's University cancer specialist's drive to improve survival rates for every European citizen
2/05/2014
Queen's University Belfast's world renowned cancer specialist, Professor Patrick Johnston, whose work has transformed cancer care in Northern Ireland, is now leading efforts to improve survival rates across Europe.
Outdoor workers in Australia face increased cancer risk
2/05/2014
Perth researchers have completed a comprehensive study into Australian workers and their exposure to Ultra Violet Radiation, which is a known human carcinogen.
Complication rates reduced by new method to restore skull after brain surgery
2/05/2014
Johns Hopkins surgeons report they have devised a better, safer method to replace bone removed from the skull after lifesaving brain surgery. The new technique, they say, appears to result in fewer complications than standard restoration, which has changed little since its development in the 1890s.
Genetic function discovered that could offer new avenue to cancer therapies
2/05/2014
Researchers at Oregon State University have discovered a genetic function that helps one of the most important "tumor suppressor" genes to do its job and prevent cancer.Finding ways to maintain or increase the effectiveness of this gene - called Grp1-associated scaffold protein, or Grasp - could offer an important new avenue for human cancer therapies, scientists said.
IDH1 mutation determines best treatment for malignant astrocytomas
2/05/2014
Astrocytomas are the most common malignant brain tumors. While most patients' tumors prove to be quite aggressive, outcomes overall can vary widely, with some patients surviving for many years. Now a new study has found that malignant astrocytoma patients whose tumors carry a specific genetic mutation benefit greatly from surgical removal of the largest possible amount of tumor.
Experts publish recommendations for managing and preventing drug shortages
2/05/2014
A group of prominent healthcare experts including bioethicists, pharmacists, policymakers and cancer specialists have proposed concrete steps for preventing and managing a nightmare scenario that is becoming all too common: shortages of life-saving drugs.
Improved understanding of cancer offered by cell division finding
2/05/2014
New insights into how the cells in our bodies divide could improve our knowledge of a condition linked to cancer, a study suggests.Errors in the cell division process - which allows us to grow and stay healthy - can lead to a genetic disorder called aneuploidy, which is also associated with birth defects and infertility.
Treatment response for acute myeloid leukemia predicted by chemical stem cell signature
2/05/2014
Researchers at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center have found a chemical "signature" in blood-forming stem cells that predicts whether patients with acute myeloid leukemia (AML) will respond to chemotherapy.The findings are based on data from nearly 700 AML patients.
Treatment response for acute myeloid leukemia predicted by chemical stem cell signature
2/05/2014
Researchers at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center have found a chemical "signature" in blood-forming stem cells that predicts whether patients with acute myeloid leukemia (AML) will respond to chemotherapy.The findings are based on data from nearly 700 AML patients.